Royalty payments and Canada's Access to Medicines Regime (English, HTML)

View metadata and access the original English HTML file: Royalty payments and Canada's Access to Medicines Regime.

Format

HTML

Access

file-only

Publisher-reported update

2020-09-17

A pharmaceutical company that holds a compulsory licence under Canada's Access to Medicines Regime is required to pay royalties to the patent holder. The company must make payments within a prescribed amount of time and in accordance with a prescribed formula.

Access original file